Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.

Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res. 2007 Oct 01; 13(19):5703-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.